Levent Ozcan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Levent Ozcan has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Alper Otunctemur
Department of Urology, Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey
14 shared publications - Emre Can Polat
Department of Urology, Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey
11 shared publications Emin Ozbek
Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey
5 shared publicationsAlper Otunctemur
4 shared publicationsEmre Can Polat
4 shared publications- Musab Umeyir Karakanli
Department of Urology, Beylikduzu State Hospital, Istanbul, Turkey
4 shared publications
Latest Publications
- 2 November 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
ASO Author Reflections: Beyond Imaging: A Blood-based Perspective on Aggressive Renal Cell Carcinoma
- 2 November 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
ASO Author Reflections: Beyond Imaging: A Blood-based Perspective on Aggressive Renal Cell Carcinoma
- 11 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-8
Correlation of Serum DR-70 Levels with Pathological Stage and Nuclear Grade in Localized Renal Cell Carcinoma
Reliable biomarkers for predicting tumor aggressiveness and pathological upstaging in renal cell carcinoma (RCC) remain limited. DR-70, a biomarker reflect
- 11 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-8
Correlation of Serum DR-70 Levels with Pathological Stage and Nuclear Grade in Localized Renal Cell Carcinoma
Reliable biomarkers for predicting tumor aggressiveness and pathological upstaging in renal cell carcinoma (RCC) remain limited. DR-70, a biomarker reflect
- Open Access
- 5 May 2026
- Published by Springer Nature in Research Square
Glycated LDL as a marker of erectile dysfunction severity in diabetes: evidence for a role of metabolic memory
Erectile dysfunction (ED) is a common complication of type 2 diabetes mellitus and is closely linked to endothelial dysfunction and metabolic disturbances. However, the relationship between glycemic control and ED severity remains inconsistent, suggesting that cumulative metabolic injury may play a more important role. In this cross-sectional comparative study, 60 diabetic patients with ED and 60 age-matched healthy controls were evaluated. ED severity was assessed using the International Index of Erectile Function-5 (IIEF-5), and patients were stratified according to ED severity and glycemic control (HbA1c <7% vs. ≥7%). Circulating glycated low-density lipoprotein (g-LDL) levels were significantly higher in patients with ED compared to controls (p < 0.001) and increased progressively with ED severity (η² = 0.39). In multivariable analysis, g-LDL (OR = 1.014, p = 0.003) and duration of diabetes (OR = 1.041, p = 0.008) were identified as independent predictors of ED severity, whereas HbA1c was not. Despite significant differences in HbA1c between controlled and uncontrolled diabetic groups (p = 0.009), no differences were observed in g-LDL levels or erectile function scores, while strong group effects were observed for g-LDL (η² = 0.76) and IIEF (η² = 0.80). These findings indicate that g-LDL is strongly associated with ED severity and may reflect cumulative metabolic injury more effectively than HbA1c, supporting the concept that long-term metabolic burden contributes to the pathogenesis of diabetic ED in line with mechanisms related to metabolic memory.
- 5 May 2026
- Published by Springer Nature in Research Square
Open AccessGlycated LDL as a marker of erectile dysfunction severity in diabetes: evidence for a role of metabolic memory
Erectile dysfunction (ED) is a common complication of type 2 diabetes mellitus and is closely linked to endothelial dysfunction and metabolic disturbances. However, the relationship between glycemic control and ED severity remains inconsistent, suggesting that cumulative metabolic injury may play a more important role. In this cross-sectional comparative study, 60 diabetic patients with ED and 60 age-matched healthy controls were evaluated. ED severity was assessed using the International Index of Erectile Function-5 (IIEF-5), and patients were stratified according to ED severity and glycemic control (HbA1c <7% vs. ≥7%). Circulating glycated low-density lipoprotein (g-LDL) levels were significantly higher in patients with ED compared to controls (p < 0.001) and increased progressively with ED severity (η² = 0.39). In multivariable analysis, g-LDL (OR = 1.014, p = 0.003) and duration of diabetes (OR = 1.041, p = 0.008) were identified as independent predictors of ED severity, whereas HbA1c was not. Despite significant differences in HbA1c between controlled and uncontrolled diabetic groups (p = 0.009), no differences were observed in g-LDL levels or erectile function scores, while strong group effects were observed for g-LDL (η² = 0.76) and IIEF (η² = 0.80). These findings indicate that g-LDL is strongly associated with ED severity and may reflect cumulative metabolic injury more effectively than HbA1c, supporting the concept that long-term metabolic burden contributes to the pathogenesis of diabetic ED in line with mechanisms related to metabolic memory.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 41
Time-dependent protective effects of syringic acid following testicular torsion–detorsion: an experimental rat model
Purpose: To investigate the protective effects of syringic acid (SA) against testicular ischemia–reperfusion (I/R) injury during different reperfusion periods in an experimental rat model. Methods: Forty-eight male Wistar albino rats were randomly assigned to six groups: control, sham, torsion/detorsion (T/D) 4 h, T/D + SA 4 h, T/D 24 h, and T/D + SA 24 h. Testicular torsion was induced by 720° rotation of the left testis for 2 h, followed by detorsion and 4 or 24 h reperfusion. SA (10 mg/kg) was administered intraperitoneally 30 min before detorsion. Oxidative stress markers, histopathological alterations, and immunohistochemical expressions of apoptotic protease activating factor-1 (APAF-1) and inducible nitric oxide synthase were evaluated. Results: T/D significantly decreased total antioxidant status and glutathione levels while increasing myeloperoxidase activity and APAF-1/inducible nitric oxide synthase (iNOS) expressions compared with controls (p < 0.001). SA treatment restored antioxidant capacity and attenuated inflammatory and apoptotic responses (p < 0.05). Histopathological analyses demonstrated lower Cosentino scores and higher Johnsen scores in SA-treated groups than in untreated T/D groups (p < 0.05). Malondialdehyde levels showed no significant intergroup differences. Conclusion: SA attenuates testicular I/R injury by reducing oxidative stress, inflammation, and apoptosis while preserving spermatogenic function and histological integrity.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 41
Open AccessTime-dependent protective effects of syringic acid following testicular torsion–detorsion: an experimental rat model
Purpose: To investigate the protective effects of syringic acid (SA) against testicular ischemia–reperfusion (I/R) injury during different reperfusion periods in an experimental rat model. Methods: Forty-eight male Wistar albino rats were randomly assigned to six groups: control, sham, torsion/detorsion (T/D) 4 h, T/D + SA 4 h, T/D 24 h, and T/D + SA 24 h. Testicular torsion was induced by 720° rotation of the left testis for 2 h, followed by detorsion and 4 or 24 h reperfusion. SA (10 mg/kg) was administered intraperitoneally 30 min before detorsion. Oxidative stress markers, histopathological alterations, and immunohistochemical expressions of apoptotic protease activating factor-1 (APAF-1) and inducible nitric oxide synthase were evaluated. Results: T/D significantly decreased total antioxidant status and glutathione levels while increasing myeloperoxidase activity and APAF-1/inducible nitric oxide synthase (iNOS) expressions compared with controls (p < 0.001). SA treatment restored antioxidant capacity and attenuated inflammatory and apoptotic responses (p < 0.05). Histopathological analyses demonstrated lower Cosentino scores and higher Johnsen scores in SA-treated groups than in untreated T/D groups (p < 0.05). Malondialdehyde levels showed no significant intergroup differences. Conclusion: SA attenuates testicular I/R injury by reducing oxidative stress, inflammation, and apoptosis while preserving spermatogenic function and histological integrity.
- Open Access
- 1 January 2026
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 79 (2) , 103-110
Is the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- 1 January 2026
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 79 (2) , 103-110
Open AccessIs the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- 21 June 2024
- Published by Elsevier in The French Journal of Urology
- Vol. 34 (9) , 102670
Is there an association between a high monocyte/high-density lipoprotein cholesterol ratio and recurrence of urethral stricture after internal urethrotomy?
- 21 June 2024
- Published by Elsevier in The French Journal of Urology
- Vol. 34 (9) , 102670
Is there an association between a high monocyte/high-density lipoprotein cholesterol ratio and recurrence of urethral stricture after internal urethrotomy?
- 17 February 2024
- Published by S. Karger AG in Urologia Internationalis
- Vol. 108 (3) , 226-233
Systemic Inflammatory Index: A Promising Non-Invasive Marker for the Prediction of Response to Neoadjuvant Chemotherapy prior to Cystectomy
Introduction: The main challenge to the optimal use of neoadjuvant chemotherapy (NAC) is the difficulty in selecting patients who may or may not benefit from NAC. Our aim in this study was to investigate whether the Systemic Inflammatory Index (SII) predicts response to chemotherapy in patients who receive NAC prior to cystectomy. Methods: We retrospectively analysed the data of patients who underwent NAC followed by cystectomy at our institution between January 2010 and September 2015 and whose 5-year follow-up was completed. All patients who underwent diagnostic biopsy with complete transurethral resection of bladder tumour at our hospital and whose pathology result was muscle-invasive transitional cell carcinoma were included in the study. At least 3 courses of gemcitabine/cisplatin NAC were given to all patients. A pathological response was defined as a reduction in cystectomy to a lower pathological stage after NAC. Results: The SII was 320.8 ± 51 in the responders and 388.28 ± 50 in the non-responders. SII optimal cut-off of 350 was determined. The sensitivity and specificity of SII in predicting response were found to be 80% and 83%, respectively. Low SII (<350) was found to be a significant predictor of response compared with the other factors on multivariate analysis. The mean overall survival time was 55.4 months in patients with a low SII value and 40.3 months in the high SII group. Conclusion: SII, together with known clinicopathological factors and newer genetic and molecular markers, can be used to select patients for NAC.
- 17 February 2024
- Published by S. Karger AG in Urologia Internationalis
- Vol. 108 (3) , 226-233
Systemic Inflammatory Index: A Promising Non-Invasive Marker for the Prediction of Response to Neoadjuvant Chemotherapy prior to Cystectomy
Introduction: The main challenge to the optimal use of neoadjuvant chemotherapy (NAC) is the difficulty in selecting patients who may or may not benefit from NAC. Our aim in this study was to investigate whether the Systemic Inflammatory Index (SII) predicts response to chemotherapy in patients who receive NAC prior to cystectomy. Methods: We retrospectively analysed the data of patients who underwent NAC followed by cystectomy at our institution between January 2010 and September 2015 and whose 5-year follow-up was completed. All patients who underwent diagnostic biopsy with complete transurethral resection of bladder tumour at our hospital and whose pathology result was muscle-invasive transitional cell carcinoma were included in the study. At least 3 courses of gemcitabine/cisplatin NAC were given to all patients. A pathological response was defined as a reduction in cystectomy to a lower pathological stage after NAC. Results: The SII was 320.8 ± 51 in the responders and 388.28 ± 50 in the non-responders. SII optimal cut-off of 350 was determined. The sensitivity and specificity of SII in predicting response were found to be 80% and 83%, respectively. Low SII (<350) was found to be a significant predictor of response compared with the other factors on multivariate analysis. The mean overall survival time was 55.4 months in patients with a low SII value and 40.3 months in the high SII group. Conclusion: SII, together with known clinicopathological factors and newer genetic and molecular markers, can be used to select patients for NAC.
- 1 November 2023
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 33 (11) , 1278-1282
Systemic Inflammatory Index: A Novel Biomarker for Predicting the Progression in Active Surveillance in Patients with Prostate Cancer
Objective: To investigate active surveillance (AS) for patients with prostate cancer to show the systemic inflammatory index (SII) progression and to evaluate whether SII will be an AS criterion in PCa patients. Study Design: Descriptive study. Place and Duration of the Study: Department of Urology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, from February 2015 to December 2021. Methodology: For active surveillance follow-up criteria, patients with prostate cancer who underwent AS with PSA 443.42) had better explanations for progression than the number of core involvement but were similar to the length of the tumour in one core. As a result of the multivariate analysis, high SII values (>443.42) and the tumour 's length in one core had similar effects on progression (in order of p = 0.011, B = 1.978, Exp(B) = 7.227, CI [1.570-33.269]; p = 0.009, B = 1.958, Exp(B) = 7.084, CI [1.642-30.555]). Conclusion: Th use of SII early in the course of treatment can help to identify which prostate cancer patients can be selected for active treatment instead of active surveillance, and to assess the probability of progression.
- 1 November 2023
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 33 (11) , 1278-1282
Systemic Inflammatory Index: A Novel Biomarker for Predicting the Progression in Active Surveillance in Patients with Prostate Cancer
Objective: To investigate active surveillance (AS) for patients with prostate cancer to show the systemic inflammatory index (SII) progression and to evaluate whether SII will be an AS criterion in PCa patients. Study Design: Descriptive study. Place and Duration of the Study: Department of Urology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, from February 2015 to December 2021. Methodology: For active surveillance follow-up criteria, patients with prostate cancer who underwent AS with PSA 443.42) had better explanations for progression than the number of core involvement but were similar to the length of the tumour in one core. As a result of the multivariate analysis, high SII values (>443.42) and the tumour 's length in one core had similar effects on progression (in order of p = 0.011, B = 1.978, Exp(B) = 7.227, CI [1.570-33.269]; p = 0.009, B = 1.958, Exp(B) = 7.084, CI [1.642-30.555]). Conclusion: Th use of SII early in the course of treatment can help to identify which prostate cancer patients can be selected for active treatment instead of active surveillance, and to assess the probability of progression.
- 25 September 2023
- Published by Elsevier in Progrès en Urologie
- Vol. 33 (15-16) , 1008-1013
Regular penis-root masturbation: A promising behavioral treatment method for lifelong premature ejaculation
- 25 September 2023
- Published by Elsevier in Progrès en Urologie
- Vol. 33 (15-16) , 1008-1013
Regular penis-root masturbation: A promising behavioral treatment method for lifelong premature ejaculation